课题基金 / 基金详情

Roles of NADPH Oxidase 5 and Dual Oxidase 2 in Cancer

Roles of NADPH Oxidase 5 and Dual Oxidase 2 in Cancer
NADPH 氧化酶 5 和双氧化酶 2 在癌症中的作用
批准号:
9343790
负责人:
James Doroshow
金额:
$54.78万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

James Doroshow的其他基金

相似基金

相关文献

中文摘要
翻译
我们的实验室已经完成了对人类肿瘤中NADPH氧化酶家族成员存在的第一次全面评估。我们发现NADPH氧化酶5(NOX 5)在黑色素瘤和血液系统恶性肿瘤中发现;双氧化酶2在各种胃肠道恶性肿瘤中发现。我们在黑色素瘤和胰腺肿瘤细胞模型系统中过度暴露或上调这两种人类蛋白质的表达,以了解它们的体外功能。已经发现NOX 5过表达下调p27,改变细胞周期进程,并在暴露于离子霉素后产生大量的细胞外过氧化氢。已经发现Duox 2过表达也导致显著程度的细胞外活性氧代谢,其可被干扰素γ诱导,干扰素γ部分地通过增强stat 1与duox 2启动子的结合而起作用。这两个基因可能在产生氧化剂“旁观者”效应中起重要作用。我们的总体目标是了解这些氧化酶在人类癌症中的功能,迄今为止尚未详细探索。
英文摘要
Our laboratory has completed one of the first comprehensive evaluations of the presence of NADPH oxidase family members in human tumors. We found that NADPH oxidase 5 (NOX 5)is found in melanomas and in hematologic malingancies; dual oxidase 2 is found in various gastrointestinal malignancies. We have either over-exposed or upregulated the expression of both of these human proteins in melanoma and pancreatic tumor cell model systems to understand their functions in vitro. NOX 5 overexpression has been found to downregulate p27, alter cell cycle progression, and generate considerable amounts of extracellular hydrogen peroxide after exposure to ionomycin. Duox 2 overexpression has been found to also lead to a remarkable degree of extracellular reactive oxygen metabolism, to be inducible with interferon gamma which functions, in part, by enhancing stat 1 binding to the duox 2 promoter. Both of these genes may play an important role in producing an oxidant "bystander" effect. Our overall goal is to understand the function of these oxidases in human cancer, which, to date has not been explored in detail.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.freeradbiomed.2013.07.005
发表时间: 2013-12
期刊: FREE RADICAL BIOLOGY AND MEDICINE
影响因子: 7.4
作者: [Antony, Smitha, Wu, Yongzhong, Hewitt, Stephen M., Anver, Miriam R., Butcher, Donna, Jiang, Guojian, Meitzler, Jennifer L., Liu, Han, Juhasz, Agnes, Lu, Jiamo, Roy, Krishnendu K., Doroshow, James H.]
通讯作者: Doroshow, James H.
DOI: 10.1016/j.freeradbiomed.2015.02.027
发表时间: 2015-07
期刊: Free radical biology & medicine
影响因子: 7.4
作者: [Carnesecchi S, Rougemont AL, Doroshow JH, Nagy M, Mouche S, Gumy-Pause F, Szanto I]
通讯作者: Szanto I
DOI: 10.1016/j.canlet.2013.08.014
发表时间: 2014-04-10
期刊: CANCER LETTERS
影响因子: 9.7
作者: [Wu, Yongzhong, Antony, Smitha, Meitzler, Jennifer L., Doroshow, James H.]
通讯作者: Doroshow, James H.
DOI: 10.4049/jimmunol.1201725
发表时间: 2013-02-15
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Wu Y, Lu J, Antony S, Juhasz A, Liu H, Jiang G, Meitzler JL, Hollingshead M, Haines DC, Butcher D, Roy K, Doroshow JH]
通讯作者: Doroshow JH
Phase 01 Clinical Trials
  • 批准号:
    8552970
  • 项目类别:
  • 资助金额:
    $39.29万
  • 财政年份:
    --
  • 负责人:
    James Doroshow
  • 依托单位:
Phase 01 Clinical Trials
  • 批准号:
    8349317
  • 项目类别:
  • 资助金额:
    $31.85万
  • 财政年份:
    --
  • 负责人:
    James Doroshow
  • 依托单位:
Roles of NADPH Oxidase 5 and Dual Oxidase 2 in Cancer
  • 批准号:
    8349316
  • 项目类别:
  • 资助金额:
    $50.96万
  • 财政年份:
    --
  • 负责人:
    James Doroshow
  • 依托单位:
Roles of NADPH Oxidase 5 and Dual Oxidase 2 in Cancer
海外基金